Healthcare & Medical Devices Global On demand · 24-48h

Global Animal Diagnostic Kit Market Strategic Research Report

Global Animal Diagnostic Kit Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Animal Diagnostic Kit Market
$1.03B2025
8.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Antigen Testing, Antibody Testing, Nucleic acid Amplification Testing, Others

By Application: Pet Hospital, Home Use

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Biovet, Randox Laboratories, Bionote, IDEXX Laboratories. Inc, Biogal, AdvaCare Pharma, MEGACOR Diagnostik, Mercodia, Fassisi GmbH, Invitek Diagnostics, Gold Standard Diagnostics, SafePath Laboratories, Prometheus Bio, Ring Biotechnology, Rapid Labs, Testsealabs, Asanpharm, Hangzhou Evegen Biotech, Affigen, J&G Biotech, Wuhan Keqian Biology Co., Ltd., Tianjin Ringpu Bio-technology Co., Ltd., Pulike Biological Engineering. Inc, Nanjing Vazyme Biotech Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 164 pages
Market size 2025
$1.03B
Billion USD
Forecast CAGR
8.5%
2025-2032
Forecast 2032
$1.8B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Animal Diagnostic Kit market size is predicted to grow from US$ 1,030 million in 2025 to US$ 1,812 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.

Animal diagnostic kits are tools used to detect and diagnose animal diseases or health conditions, usually containing specific biochemical reagents, antibodies, antigens or nucleic acid probes, etc. They help veterinarians, farms or laboratories determine the health status, disease type and infection level of animals by quickly and accurately identifying pathogens (such as viruses, bacteria, parasites) or detecting immune responses and metabolites in animals.

The animal diagnostic kit market is booming, driven by several factors:Rising pet ownership: more and more people considering their pets as family members. This surge in pet ownership translates to increased demand for preventative care and early diagnosis of health issues. Technological advancements: Advancements in biotechnology and medical technology have led to the development of faster, more accurate, and easier-to-use diagnostic tools. Point-of-care tests, for example, allow veterinarians to get immediate results without sending samples to a lab, leading to quicker diagnoses and treatment decisions. Growing focus on preventative care: Pet owners are becoming increasingly aware of the importance of preventative healthcare for their animals. This includes regular checkups, vaccinations, and early detection of diseases. Animal diagnostic kits play a crucial role in this by providing vets with the tools to identify potential health problems at an early stage, when they are more treatable. Increased awareness of animal health: There is a growing awareness of animal welfare and the importance of providing pets with quality veterinary care. This has led to increased spending on pet health, including on diagnostic kits. Market challenges: Despite the positive outlook, the animal diagnostic kit market faces some challenges: Cost: Some diagnostic kits can be expensive, which may limit their accessibility to some pet owners. Regulation: The regulatory landscape for animal diagnostic kits varies from country to country, which can create challenges for manufacturers and distributors. Veterinarian education and training: Not all veterinarians are familiar with the latest diagnostic technologies, which may limit their use of these kits. Overall, the animal diagnostic kit market is expected to continue growing in the coming years, driven by the increasing demand for pet healthcare, technological advancements, and a growing focus on preventative care.

This report presents a comprehensive overview of the global Animal Diagnostic Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Antigen Testing
  • Antibody Testing
  • Nucleic acid Amplification Testing
  • Others

Segment by Application

  • Pet Hospital
  • Home Use

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Animal Diagnostic Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pet Hospital, Home Use evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Animal Diagnostic Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.03B
2025
Forecast
$1.8B
2032
CAGR
8.5%
2025–2032
リージョン
5
global
Key companies
BiovetRandox LaboratoriesBionoteIDEXX Laboratories. IncBiogalAdvaCare PharmaMEGACOR DiagnostikMercodia
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Antigen TestingAntibody TestingNucleic acid Amplification TestingOthers
By Application
Pet HospitalHome Use

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Antigen Testing
  • 3.1.3 Antibody Testing
  • 3.1.4 Nucleic acid Amplification Testing
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pet Hospital
  • 4.1.3 Home Use
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Biovet
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Randox Laboratories
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Bionote
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 IDEXX Laboratories. Inc
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Biogal
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 AdvaCare Pharma
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 MEGACOR Diagnostik
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Mercodia
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Fassisi GmbH
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Invitek Diagnostics
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Gold Standard Diagnostics
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 SafePath Laboratories
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Prometheus Bio
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Ring Biotechnology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Rapid Labs
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Testsealabs
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Asanpharm
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Hangzhou Evegen Biotech
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Affigen
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 J&G Biotech
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Wuhan Keqian Biology Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Tianjin Ringpu Bio-technology Co.,Ltd.
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Pulike Biological Engineering. Inc
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Nanjing Vazyme Biotech Co., Ltd.
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Animal Diagnostic Kit market?
The global Animal Diagnostic Kit market is estimated at US$ 1.03 billion in 2025 (base year) and is projected to reach US$ 1.81 billion by 2032.
What is the forecast CAGR for the Animal Diagnostic Kit market?
The market is expected to grow at a CAGR of 8.5% from 2026 to 2032, expanding from US$ 1.03 billion in 2025 to US$ 1.81 billion in 2032, roughly 1.8 times its base-year value.
What is Animal Diagnostic Kit?
Animal diagnostic kits are tools used to detect and diagnose animal diseases or health conditions, usually containing specific biochemical reagents, antibodies, antigens or nucleic acid probes, etc. They help veterinarians, farms or laboratories determine the health status, disease type and infection level of animals by quickly and accurately identifying pathogens (such as viruses, bacteria, parasites) or detecting immune responses and metabolites in animals.
What are the main segments of the Animal Diagnostic Kit market by type?
By type, the market is segmented into Antigen Testing, Antibody Testing, Nucleic acid Amplification Testing and Others.
Which applications drive demand in the Animal Diagnostic Kit market?
Key applications covered include Pet Hospital and Home Use.
Who are the key players in the Animal Diagnostic Kit market?
Key players profiled include Biovet, Randox Laboratories, Bionote, IDEXX Laboratories. Inc, Biogal, AdvaCare Pharma, MEGACOR Diagnostik and Mercodia, among 24 companies covered in total.
Which regions and countries are covered for Animal Diagnostic Kit?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Animal Diagnostic Kit market?
The animal diagnostic kit market is booming, driven by several factors:Rising pet ownership: more and more people considering their pets as family members.
What challenges does the Animal Diagnostic Kit market face?
Market challenges: Despite the positive outlook, the animal diagnostic kit market faces some challenges: Cost: Some diagnostic kits can be expensive, which may limit their accessibility to some pet owners.
Who should buy the Animal Diagnostic Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pet Hospital and Home Use, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Animal Diagnostic Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.